VTI1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.605600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.017400E-01
Normal-vs-Stage2
3.796200E-01
Normal-vs-Stage3
1.017150E-01
Normal-vs-Stage4
8.636800E-01
Stage1-vs-Stage2
9.236400E-01
Stage1-vs-Stage3
1.569600E-01
Stage1-vs-Stage4
2.628200E-01
Stage2-vs-Stage3
8.804100E-02
Stage2-vs-Stage4
1.998840E-01
Stage3-vs-Stage4
5.734000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.345600E-01
Normal-vs-AfricanAmerican
6.750600E-01
Normal-vs-Asian
5.540000E-01
Caucasian-vs-AfricanAmerican
5.933200E-01
Caucasian-vs-Asian
5.076400E-01
AfricanAmerican-vs-Asian
9.717200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.926600E-01
Normal-vs-Female
3.354600E-01
Male-vs-Female
6.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.212600E-01
Normal-vs-Age(41-60Yrs)
5.788400E-01
Normal-vs-Age(61-80Yrs)
2.900400E-01
Normal-vs-Age(81-100Yrs)
2.679400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.323800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.742400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.268000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.521800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.184400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.490000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.017600E-01
Normal-vs-Daily Drinker
4.102400E-01
Normal-vs-Weekly Drinker
3.494600E-01
Normal-vs-Occasional Drinker
7.753000E-01
Normal-vs-Social Drinker
1.883990E-01
Non Drinker-vs-Daily Drinker
8.625000E-01
Non Drinker-vs-Weekly Drinker
7.796200E-01
Non Drinker-vs-Occasional Drinker
2.604600E-01
Non Drinker-vs-Social Drinker
5.802600E-01
Daily Drinker-vs-Weekly Drinker
9.135800E-01
Daily Drinker-vs-Occasional Drinker
2.498800E-01
Daily Drinker-vs-Social Drinker
7.346000E-01
Weekly Drinker-vs-Occasional Drinker
2.285400E-01
Weekly Drinker-vs-Social Drinker
8.253800E-01
Occasional Drinker-vs-Social Drinker
1.130760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.022410E-01
Normal-vs-Grade 2
3.423500E-03
Normal-vs-Grade 3
1.080900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.695600E-03
Grade 1-vs-Grade 3
2.364300E-02
Grade 1-vs-Grade 4
1.022410E-01
Grade 2-vs-Grade 3
9.848200E-01
Grade 2-vs-Grade 4
3.423500E-03
Grade 3-vs-Grade 4
1.080900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.042800E-01
Normal-vs-NonDiabetic
2.969600E-01
Diabetic-vs-NonDiabetic
6.907200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.810600E-01
Normal-vs-NoPancreatitis
3.193800E-01
Pancreatitis-vs-NoPancreatitis
1.395400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.755600E-01
Normal-vs-N1
3.836800E-01
N0-vs-N1
8.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.825600E-01
Normal-vs-TP53-NonMutant
3.275200E-01
TP53-Mutant-vs-TP53-NonMutant
1.380340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
